Skip to main content
. 2017 Feb 22;10:55. doi: 10.1186/s13045-017-0417-z

Fig. 7.

Fig. 7

Mean blood counts over time in the ruxolitinib randomized and ruxolitinib crossover groups. Blood counts were based on measurements of a hemoglobin level, b platelet counts, and c white blood cell counts. *For patients in the ruxolitinib crossover group, BL represents the date of crossover to ruxolitinib. BL, baseline